This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Texas A&M University System, University of California, University of South Florida. Active years: 2021-2024.
Company Filing History:
5 out of 1,326 
1 out of 15,988 
1 out of 1,985 
Years Active: 2021-2024
Title: Scott Victor Dindot: Pioneering Advances in Angelman Syndrome Research
Introduction
Scott Victor Dindot is an innovative inventor based in College Station, TX (US), recognized for his significant contributions to the field of genetics and neurobiology. With a total of five patents to his name, Dindot is at the forefront of developing potential treatments for Angelman syndrome, a rare genetic disorder.
Latest Patents
Dindot's latest patents demonstrate his commitment to improving the understanding and treatment of Angelman syndrome. One notable patent involves antisense oligonucleotides designed to induce the expression of ubiquitin-protein ligase E3A (UBE3A) from the paternal allele in human neurons. These oligonucleotides effectively target the suppressor of the UBE3A paternal allele by hybridizing to SNHG14 long non-coding RNA, with implications for developing pharmaceutical compositions for treating Angelman syndrome.
Another significant patent concerns an animal model of Angelman syndrome. This invention features non-human animals with a genome lacking the entire E3 ubiquitin ligase (Ube3a) gene, which is crucial for modeling the disease. Dindot's work includes methods for assessing how various agents, such as potential therapeutics, impact these animal models, paving the way for future breakthroughs in treatment options.
Career Highlights
Dindot has contributed to advancing genetic research through his tenure at esteemed institutions, including The Texas A&M University System and the University of South Florida. His research has focused on understanding genetic disorders and developing viable treatments, highlighting his dedication to enhancing the quality of life for individuals affected by Angelman syndrome.
Collaborations
Throughout his career, Dindot has collaborated with notable researchers such as Edwin John Weeber and David J Segal. These partnerships have fostered an environment of innovation, enabling the exploration of new avenues in genetic research and therapeutic approaches.
Conclusion
Scott Victor Dindot stands out as a prominent figure in the field of genetic research, particularly for his work on Angelman syndrome. His patents underscore the potential for innovative treatments that could transform the lives of those affected by this disorder. As he continues to push the boundaries of knowledge in his field, Dindot's contributions will undoubtedly leave a lasting impact on the scientific community and the patients it serves.